Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01639144 · ClinicalTrials.gov registry record · NA
Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing
A NA study of Elective Foot and Ankle Surgery., sponsored by Gary M. Kiebzak, Ph.D..
- Completed
- Registry status
- NA
- Development phase
- 515
- Enrollment target
- 1
- Study location
NCT01639144 is a NA study of Elective Foot and Ankle Surgery. that has completed, run by Gary M. Kiebzak, Ph.D.. The registered enrollment target is 515 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01639144, a NA study of Elective Foot and Ankle Surgery., has completed, sponsored by Gary M. Kiebzak, Ph.D..
- COMPLETED
- Registry status
- NA
- Development phase
- 515 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.
Conditions Studied
Interventions
- BIOLOGICAL PRP and PPP
Study Locations (1)
Florida
- UHZ Sports Medicine Institute - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01639144
The ClinicalTrials.gov registry entry for NCT01639144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 515 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gary M. Kiebzak, Ph.D., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Elective Foot and Ankle Surgery. appearing as the primary indexed condition, and to 1 intervention - of which PRP and PPP is the first listed.
NCT01639144 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01639144 about?
NCT01639144 is a clinical study titled "Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing". The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.
What is the current status of trial NCT01639144?
This trial is currently completed. It is a NA study. The enrollment target is 515 participants. The study started on 2012-07. Estimated completion is 2015-03.
What conditions does trial NCT01639144 study?
This clinical trial studies the following conditions: Elective Foot and Ankle Surgery..
What interventions are being tested in trial NCT01639144?
The interventions under investigation include: PRP and PPP (BIOLOGICAL).
Who is sponsoring clinical trial NCT01639144?
This trial is sponsored by Gary M. Kiebzak, Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01639144 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.